Diagnosed arthritis afflicts 22% of the U.S. population and is projected to affect the lives of as many as 50 percent by 2030. Aging baby boomers are creating the largest senior citizen demographic in history, as well as one of the biggest disease indication growth markets. The BioWorld & Medical Device Daily Arthritis Report 2009: Drug and Med-Tech Innovation and Economics report delivers thorough med-tech-specific data and strong analysis on the arthritis phenomenon, covering a range of topics, from current devices to ground-breaking regenerative technology procedures.
This report also details the promising prospects for investors in the field and provides a practical assessment of the comparative R&D landscape. Order the BioWorld & Medical Device Daily Arthritis Report 2009 risk-free for 30 days for only $599 (plus $17.95 shipping and handling). Or call 1-800-688-2421 or 1-404-262-5476 and mention priority code S08443.